Therapeutic equivalence of lansoprzole and esomeprazole (multiple letters)

Philip Schoenfeld, Colin Howden, E. David Ballard, Weining Robieson

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)415-416
Number of pages2
JournalClinical Drug Investigation
Volume22
Issue number6
StatePublished - Jun 25 2002
Externally publishedYes

Fingerprint

Esomeprazole
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pharmacology (medical)

Cite this

Therapeutic equivalence of lansoprzole and esomeprazole (multiple letters). / Schoenfeld, Philip; Howden, Colin; Ballard, E. David; Robieson, Weining.

In: Clinical Drug Investigation, Vol. 22, No. 6, 25.06.2002, p. 415-416.

Research output: Contribution to journalLetter

Schoenfeld, P, Howden, C, Ballard, ED & Robieson, W 2002, 'Therapeutic equivalence of lansoprzole and esomeprazole (multiple letters)', Clinical Drug Investigation, vol. 22, no. 6, pp. 415-416.
Schoenfeld, Philip ; Howden, Colin ; Ballard, E. David ; Robieson, Weining. / Therapeutic equivalence of lansoprzole and esomeprazole (multiple letters). In: Clinical Drug Investigation. 2002 ; Vol. 22, No. 6. pp. 415-416.
@article{17b695069f7e4bd0af5bd78a7150ed7e,
title = "Therapeutic equivalence of lansoprzole and esomeprazole (multiple letters)",
author = "Philip Schoenfeld and Colin Howden and Ballard, {E. David} and Weining Robieson",
year = "2002",
month = "6",
day = "25",
language = "English (US)",
volume = "22",
pages = "415--416",
journal = "Clinical Drug Investigation",
issn = "1173-2563",
publisher = "Adis International Ltd",
number = "6",

}

TY - JOUR

T1 - Therapeutic equivalence of lansoprzole and esomeprazole (multiple letters)

AU - Schoenfeld, Philip

AU - Howden, Colin

AU - Ballard, E. David

AU - Robieson, Weining

PY - 2002/6/25

Y1 - 2002/6/25

UR - http://www.scopus.com/inward/record.url?scp=0036279383&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036279383&partnerID=8YFLogxK

M3 - Letter

VL - 22

SP - 415

EP - 416

JO - Clinical Drug Investigation

JF - Clinical Drug Investigation

SN - 1173-2563

IS - 6

ER -